To the Editor:
We read with great interest the article by Aries et al, 1 in which they studied near infrared spectroscopy (NIRS) to monitor 9 patients with ischemic stroke who had more "desaturations" in the affected hemisphere than the nonaffected hemisphere. Their study raises questions of why this would pathophysiologically occur, such as different collateral flow or differential cerebral O 2 consumption after stroke. We believe NIRS is an emerging method of measuring mixed arterial-venous brain tissue oxygenation with its primary advantage being a noninvasive procedure (versus invasive brain tissue PbO 2 , Licox probes, etc) as well as having a simple application and continuous trending capability for cerebral desaturations. The disadvantages of NIRS technology is that it provides only "regional" saturation of oxygen probe information, similar to other, typically invasive, neurointensive care unit probes such as Licox PbO 2 , intracranial pressure probes, or Hemedex cerebral blood flow sensors. Despite these limitations, we believe that NIRS probes have the potential to be useful for managing patients with stroke and NIRS regional saturation of oxygen correlates with CT perfusion-derived regional cerebral blood flow 2 
